SCHEMBL8658166

SCHEMBL8658166

C=C1NC(SCc2ccccc2N(C)C)=NC1=O

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.39
ATP4A P20648 1/20 0.37
ATP4B P51164 1/20 0.37
HPGD P15428 3/20 0.35
LMNA P02545 3/20 0.35
MAPK1 P28482 3/20 0.35
MAPT P10636 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
POLB P06746 1/20 0.35
TSHR P16473 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALDH1A1 P00352 2/20 0.35
KMT2A Q03164 2/20 0.33
PKM P14618 1/20 0.33
NSD2 O96028 1/20 0.33
EGFR P00533 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8654394 0.81 AR (0.38) ARATP4AATP4BHPGDLMNA
Hydrochloric Acid SCHEMBL8656854 0.80 AR (0.37) ARATP4AATP4BHPGDLMNA
SCHEMBL8654755 0.80 KDM4E (0.41) ARATP4AATP4BHPGDLMNA
SCHEMBL8654756 0.80 KDM4E (0.41) ARATP4AATP4BHPGDLMNA
SCHEMBL8658153 0.79 AR (0.36) ARATP4AATP4BHPGDLMNA
SCHEMBL8656860 0.79 AR (0.36) ARATP4AATP4BHPGDLMNA
SCHEMBL8656716 0.79 AR (0.34) ARATP4AATP4BHPGDLMNA
SCHEMBL8656613 0.78 AR (0.36) ARATP4AATP4BHPGDLMNA
SCHEMBL8655331 0.77 AR (0.35) ARATP4AATP4BHPGDLMNA
SCHEMBL8656211 0.77 HPGD (0.39) ARATP4AATP4BHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5733922-A Imidazole derivative, pharmaceutically acceptable salt thereof, and anti-ulcer drug including such derivative or salt ARAX CO., LTD. (JP) 1998-03-31 US disclosed
EP-0728747-A1 Imidazole derivative, pharmaceutically acceptable salt thereof, process of manufacture therefor, and anti-ulcer drug including such derivative or salt ARAX CO., LTD. (JP) 1996-08-28 EP disclosed